4//SEC Filing
Ottinger Bradley 4
Accession 0000805928-22-000032
CIK 0000805928other
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 4:09 PM ET
Size
14.3 KB
Accession
0000805928-22-000032
Insider Transaction Report
Form 4
Axogen, Inc.AXGN
Ottinger Bradley
General Counsel and CCO
Transactions
- Award
Common Stock
2022-03-16+2,563→ 3,721 total - Award
Employee Stock Option (right to purchase)
2022-03-16+41,948→ 41,948 totalExercise: $8.20Exp: 2032-03-16→ Common Stock (41,948 underlying) - Tax Payment
Common Stock
2022-03-16$7.97/sh−648$5,165→ 3,073 total - Award
Restricted Stock Units
2022-03-16+44,973→ 44,973 total→ Common Stock (44,973 underlying) - Exercise/Conversion
Restricted Stock Units
2022-03-16−2,563→ 5,127 total→ Common Stock (2,563 underlying)
Footnotes (7)
- [F1]This reflects the number of restricted stock units that became vested as of March 16, 2022.
- [F2]Includes 1,158 shares acquired under the Axogen stock purchase plan in 2021.
- [F3]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- [F4]Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.
- [F5]All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2024 (3 years from the grant date) based upon a vesting schedule whereby 33.33% of the aggregate shares vest on March 16, 2022, 33.33% of the aggregate shares vest on March 16, 2023, and 33.34% of the aggregate shares vest on March 16, 2024. Vested shares will be delivered to the reporting person upon the vesting date.
- [F6]All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2026 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregateshares vest on March 16, 2024 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date.
- [F7]All shares of Axogen, Inc. common stock underlying the employee stock option will be fully vested on March 16, 2026 (4 years from the option grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 16, 2024 (24 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter.
Documents
Issuer
Axogen, Inc.
CIK 0000805928
Entity typeother
Related Parties
1- filerCIK 0001813381
Filing Metadata
- Form type
- 4
- Filed
- Mar 17, 8:00 PM ET
- Accepted
- Mar 18, 4:09 PM ET
- Size
- 14.3 KB